Theravance Biopharma (TBPH) Restructuring Costs (2021 - 2026)
Theravance Biopharma (TBPH) posted quarterly Restructuring Costs of $2.6 million for Q1 2026, up 122.84% quarter-over-quarter from $1.2 million in Q2 2023.
Theravance Biopharma (TBPH) Restructuring Costs (2021 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has reported Restructuring Costs for 4 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs changed N/A year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $3.8 million (changed N/A YoY), while the FY2023 annual figure was $2.7 million, down 78.57% from the prior year.
- Restructuring Costs advanced to $2.6 million in Q1 2026 per TBPH's latest filing, from $1.2 million in the prior quarter.
- Across five years, Restructuring Costs topped out at $33.0 million in Q3 2022 and bottomed at -$38000.0 in Q4 2022.
- Historically, Restructuring Costs has averaged $11.9 million across 3 years, with a median of $2.6 million in 2026.
- On a YoY basis, Restructuring Costs climbed as much as 114.29% in 2022 and fell as far as 100.21% in 2022.
- Theravance Biopharma's Restructuring Costs stood at -$38000.0 in 2022, then surged by 3176.32% to $1.2 million in 2023, then jumped by 122.84% to $2.6 million in 2026.
- Business Quant data shows TBPH's Restructuring Costs at $2.6 million in Q1 2026, $1.2 million in Q2 2023, and $1.6 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.03 Mn |
| Mar 31, 2026 | 2.61 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.57 Mn |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 15.40 Mn |
| Mar 31, 2022 | 29.50 Mn |
| Dec 31, 2021 | 18.33 Mn |
| Sep 30, 2021 | 15.40 Mn |